MX BIO
Latest round
- Series B
Last raised
- Apr 2026
Total raised
- $12M
Investors
- 6
About MX BIO
Based in South Korea, MX BIO Inc. specializes in biotechnology solutions, focusing on developing and manufacturing diagnostic tools and therapeutic products for healthcare professionals and research institutions. MX BIO Inc. is a biotechnology company founded in 2018 and headquartered in Seoul, South Korea. The CEO of the company is Jae Lee, who has a history of leadership in the biotech sector. MX BIO Inc. specializes in innovative biotechnology solutions, primarily focusing on the development and manufacturing of advanced diagnostic tools and therapeutic products. Their core offerings include proprietary assays and kits for the rapid and accurate detection of various biological markers essential in clinical diagnostics and research applications.MX BIO Inc. generates revenue through a structured framework of direct-to-consumer and business-to-business transactions. The company primarily relies on the sale of its diagnostic products, often contracted with hospitals and laboratories under bulk purchase agreements or subscription models.In March 2020, MX BIO Inc. Additionally, MX BIO Inc. aims to launch new products designed to meet the ongoing demands of the healthcare market while targeting expansion into new geographic regions to increase its market presence.
Who invested in MX BIO
6 investors across 4 rounds
See all investors in MX BIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MX BIO
Who invested in MX BIO?
MX BIO has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MX BIO raised?
MX BIO has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did MX BIO last raise money?
MX BIO's most recent round on record is a Series B, in Apr 2026.
What does MX BIO do?
Based in South Korea, MX BIO Inc.
Where is MX BIO headquartered?
MX BIO is headquartered in Seoul, South Korea.
Which VCs invest in companies like MX BIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at MX BIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like MX BIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.